MEDICAL PROPERTIES TRUST INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MEDICAL PROPERTIES TRUST INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $972.02M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $995.55M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $871.80M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.54B | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $1.54B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.25B | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $256.44M | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $224.76M | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $192.55M | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $180.45M | Feb 27, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($277.05M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | ($2.41B) | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | ($556.48M) | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $902.60M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $656.02M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $431.45M | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | $129.64M | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $89.79M | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $79.44M | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $75.82M | Feb 27, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $485.58M | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | $341.64M | Mar 1, 2018 |
| FY2017 | Dec 31, 2015 | $263.24M | Mar 1, 2018 |
| FY2016 | Dec 31, 2014 | $142.95M | Mar 1, 2017 |
| FY2015 | Dec 31, 2013 | $153.54M | Feb 29, 2016 |
| FY2014 | Dec 31, 2012 | $129.85M | Mar 2, 2015 |
| FY2013 | Dec 31, 2011 | $70.18M | Mar 3, 2014 |
| FY2012 | Dec 31, 2010 | $42.21M | Feb 22, 2013 |
| FY2011 | Dec 31, 2009 | $67.55M | Feb 29, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $230.77M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $245.48M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $505.79M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $739.01M | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | $811.66M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $617.64M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $494.12M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $449.09M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $362.24M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $263.84M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.00B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $14.29B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $18.30B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $19.66B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $20.52B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $16.83B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $14.47B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $8.84B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $9.02B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $6.42B | Mar 1, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.39B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $9.46B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $10.67B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $11.06B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $12.07B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $9.49B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $7.44B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $4.28B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $5.19B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $3.17B | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.61B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $4.83B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $7.63B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $8.59B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $8.44B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $7.34B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $7.03B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $4.55B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $3.82B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $3.25B | Mar 1, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($4.14B) | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | ($3.66B) | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | ($971.81M) | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $116.29M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($87.69M) | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | ($71.41M) | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $83.01M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $162.77M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | ($485.93M) | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | ($434.11M) | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $540.86M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $332.34M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $250.02M | Feb 26, 2026 |
| FY2025 | Dec 31, 2022 | $235.67M | Feb 26, 2026 |
| FY2024 | Dec 31, 2021 | $459.23M | Mar 3, 2025 |
| FY2023 | Dec 31, 2020 | $549.88M | Feb 29, 2024 |
| FY2022 | Dec 31, 2019 | $1.46B | Mar 1, 2023 |
| FY2021 | Dec 31, 2018 | $820.87M | Mar 1, 2022 |
| FY2020 | Dec 31, 2017 | $171.47M | Mar 1, 2021 |
| FY2019 | Dec 31, 2016 | $83.24M | Feb 27, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.70B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $8.85B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $10.06B | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | $10.27B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $11.28B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $8.87B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $7.02B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $4.04B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $4.90B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $2.91B | Mar 1, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | (4) | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 27, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | (4) | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 1 | Mar 3, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 27, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 597.01M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 600.40M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 598.99M | Mar 3, 2025 |
| FY2023 | Dec 31, 2022 | 597.48M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 596.75M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | 541.42M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | 517.52M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | 370.64M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 364.42M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 320.51M | Mar 1, 2018 |